The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease

Summary

This study aims to evaluate the effect of 8 weeks of a stress reduction intervention on atherosclerotic plaque inflammation in adults with stable coronary artery disease, as quantified by positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in individuals with increased psychosocial stress.

Eligibility

Inclusion Criteria:

* Must admit to feeling stressed and/or have PSS score \> 13 (moderate stress)
* Must be willing to complete stress reduction course and imaging sessions with \< 3 missed appointments in last year
* Known clinical cardiovascular disease with prior atherosclerotic myocardial infarction, percutaneous intervention or bypass surgery \> 6 months before entry, or severe coronary calcifications on computed tomography or coronary calcium score \>400
* Stable symptoms without symptomatic heart failure or arrhythmia or planned revascularization
* Maximally tolerated and stable medical regimen for 90 days that does not include a high intensity statin for clinical reasons
* No neurological disease or systemic inflammatory disease/current anti-inflammatory therapy
* No active psychiatric disease/medications or substance abuse (including tobacco smoking or more than moderate alcohol) for last 6 months
* No current participation in cardiac rehab or prior participation in stress reduction
* For imaging: no pregnancy, weight \> 300 lbs., metal implants, uncontrolled hyperglycemia, or inability to provide consent or comply

Conditions4

Locations1 site

Browse More Trials